Bioxytran (BIXT) Short Interest Ratio & Short Volume $0.09 -0.01 (-7.01%) As of 07/11/2025 03:49 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Bioxytran Short Interest DataBioxytran (BIXT) has a short interest of 100 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a -99.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 84,248 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest10,200 sharesChange Vs. Previous Month-99.02%Dollar Volume Sold Short$10.48Short Interest Ratio0.0 Days to CoverLast Record DateJune 30, 2025Outstanding Shares88,992,000 sharesShort Percent of Float0.00%Today's Trading Volume34,505 sharesAverage Trading Volume84,248 sharesToday's Volume Vs. Average41% Short Selling Bioxytran? Sign up to receive the latest short interest report for Bioxytran and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBIXT Short Interest Over TimeBIXT Days to Cover Over TimeBIXT Percentage of Float Shorted Over Time Bioxytran Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025100 shares $10.48 -99.0%0.0%0 $0.10 6/15/202510,200 shares $1.10 thousand +229.0%0.0%0 $0.11 5/31/20253,100 shares $456.94 No Change0.0%0 $0.15 4/30/202512,800 shares $2.05 thousand -66.4%N/A0.1 $0.16 4/15/202538,100 shares $6.83 thousand -54.5%0.1%0.1 $0.18 3/31/202583,800 shares $11.82 thousand +70.3%0.3%0.1 $0.14 3/15/202549,200 shares $9.59 thousand +693.6%0.2%0 $0.19 2/28/20256,200 shares $492.28 -13.9%0.0%0 $0.08 2/15/20257,200 shares $576.00 -82.4%0.0%0.1 $0.08 1/31/202541,000 shares $4.10 thousand No ChangeN/A0.2 $0.10 Get the Latest News and Ratings for BIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bioxytran and its competitors with MarketBeat's FREE daily newsletter. 1/15/202510,300 shares $965.11 -86.7%N/A0.1 $0.09 12/31/202410,300 shares $925.97 -86.7%N/A0.1 $0.09 12/15/202477,600 shares $6.84 thousand +254.3%N/A0.9 $0.09 11/30/202421,900 shares $2.03 thousand +4.3%N/A0.2 $0.09 11/15/202421,000 shares $1.94 thousand No ChangeN/A0.1 $0.09 10/15/2024100 shares $9.80 -99.1%N/A0 $0.10 9/30/202411,600 shares $1.28 thousand No ChangeN/A0.1 $0.11 7/31/202438,600 shares $4.62 thousand +235.7%N/A0.3 $0.12 7/15/202411,500 shares $972.90 +26.4%N/A0.1 $0.08 6/30/20249,100 shares $877.24 +225.0%N/A0 $0.10 6/15/20242,800 shares $294.00 -77.6%N/A0 $0.11 5/31/202412,500 shares $1.56 thousand No ChangeN/A0.1 $0.12 4/30/202423,100 shares $2.57 thousand +192.4%N/A0.1 $0.11 4/15/20247,900 shares $1.15 thousand -86.0%N/A0 $0.15 3/31/202456,600 shares $5.99 thousand +4.0%N/A0.5 $0.11 3/15/202454,400 shares $6.05 thousand +92.9%N/A0.3 $0.11 2/29/202428,200 shares $3.10 thousand No ChangeN/A0.2 $0.11 1/15/20241,700 shares $244.12 -89.5%N/A0 $0.14 12/31/202316,200 shares $2.43 thousand -46.9%N/A0 $0.15 12/15/202330,500 shares $4.48 thousand No ChangeN/A0.1 $0.15 11/15/202347,500 shares $7.12 thousand +268.2%N/A0.4 $0.15 10/31/202312,900 shares $2.00 thousand -77.0%N/A0.1 $0.16 10/15/202356,100 shares $9.54 thousand +2.2%N/A0.5 $0.17 9/30/202354,900 shares $9.33 thousand +173.1%N/A0.2 $0.17 9/15/202320,100 shares $3.02 thousand -71.6%N/A0 $0.15 8/31/202370,700 shares $21.92 thousand +644.2%N/A0.3 $0.31 8/15/20239,500 shares $1.37 thousand +106.5%N/A0.2 $0.14 7/31/20234,600 shares $687.70 -87.9%N/A0 $0.15 7/15/202338,100 shares $5.72 thousand -25.3%N/A0.4 $0.15 6/30/202351,000 shares $9.69 thousand +4,150.0%N/A0.2 $0.19Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 6/15/20231,200 shares $276.00 -62.5%N/A0 $0.23 5/31/20233,200 shares $1.03 thousand +88.2%N/A0.1 $0.32 5/15/20231,700 shares $680.00 -96.0%N/A0 $0.40 4/30/202342,900 shares $21.77 thousand +263.6%N/A0.7 $0.51 4/15/202311,800 shares $5.74 thousand -9.2%N/A0.1 $0.49 3/31/202313,000 shares $5.79 thousand +14.0%N/A0.1 $0.45 3/15/202311,400 shares $5.14 thousand No ChangeN/A0 $0.45 2/15/2023700 shares $292.25 No ChangeN/A0 $0.42 1/15/202317,400 shares $7.83 thousand -17.1%N/A0.3 $0.45 12/30/202221,000 shares $10.08 thousand +577.4%N/A0.2 $0.48 12/15/20223,100 shares $1.29 thousand +121.4%N/A0 $0.42 11/30/20221,400 shares $588.14 -90.1%N/A0 $0.42 11/15/202214,200 shares $7.10 thousand +136.7%N/A0.1 $0.50 10/31/20226,000 shares $2.40 thousand +185.7%N/A0.1 $0.40 10/15/20222,100 shares $1.07 thousand No ChangeN/A0 $0.51 9/15/20227,400 shares $6.96 thousand -54.6%N/A0 $0.94 8/31/202216,300 shares $16.95 thousand +3,160.0%N/A0.1 $1.04 8/15/2022500 shares $255.00 -73.7%N/A0 $0.51 7/31/20221,900 shares $798.00 -88.3%N/A0 $0.42 7/15/202216,200 shares $8.91 thousand No ChangeN/A0.1 $0.55 12/31/2021300 shares $120.00 No ChangeN/A0 $0.40 12/15/2021300 shares $0.75 -25.0%N/A0.1 $0.00 11/30/2021400 shares $8.00 No ChangeN/A0.1 $0.02 11/15/2021400 shares $1.00 No ChangeN/A1 $0.00 10/29/2021400 shares $1.00 No ChangeN/A0.4 $0.00 10/15/2021400 shares $1.24 No ChangeN/A4 $0.00 9/30/2021400 shares $0.44 No ChangeN/A0 $0.00 9/15/2021400 shares $0.20 No ChangeN/A1.3 $0.00 8/31/2021400 shares $0.20 No ChangeN/A0.3 $0.00 8/13/2021400 shares $0.20 No ChangeN/A2 $0.00 7/30/2021400 shares $0.12 No ChangeN/A0.1 $0.00 7/15/2021400 shares $4.48 No ChangeN/A0.3 $0.01 6/30/2021400 shares $0.08 No ChangeN/A0.3 $0.00 6/15/2021400 shares $0.08 No ChangeN/A2 $0.00 5/28/2021400 shares $0.40 No ChangeN/A0.4 $0.00 5/14/2021400 shares $68.00 No ChangeN/A0.1 $0.17 4/30/2021400 shares $52.00 No ChangeN/A0 $0.13 4/15/2021400 shares $28.00 No ChangeN/A0.1 $0.07 3/31/2021400 shares $68.00 No ChangeN/A4 $0.17 3/15/2021400 shares $72.00 No ChangeN/A0.3 $0.18 2/26/2021400 shares $72.00 No ChangeN/A0.3 $0.18 2/12/2021400 shares $72.00 No ChangeN/A0.7 $0.18 1/29/2021400 shares $77.50 No ChangeN/A0.1 $0.19 1/15/2021400 shares $96.00 No ChangeN/A0.3 $0.24 12/31/2020400 shares $96.00 No ChangeN/A0.2 $0.24 12/15/2020400 shares $112.00 No ChangeN/A0.3 $0.28 BIXT Short Interest - Frequently Asked Questions What is Bioxytran's current short interest? Short interest is the volume of Bioxytran shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 100 shares of BIXT short. 0.00% of Bioxytran's shares are currently sold short. Learn More on Bioxytran's current short interest. What is a good short interest percentage for Bioxytran? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Bioxytran's floating shares are currently sold short. Is Bioxytran's short interest increasing or decreasing? Bioxytran saw a decrease in short interest in June. As of June 30th, there was short interest totaling 100 shares, a decrease of 99.0% from the previous total of 10,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Bioxytran's short interest compare to its competitors? 0.00% of Bioxytran's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bioxytran: Acrivon Therapeutics, Inc. (3.45%), Karyopharm Therapeutics Inc. (25.50%), Telomir Pharmaceuticals, Inc. (8.41%), Mersana Therapeutics, Inc. (10.59%), PepGen, Inc. (4.78%), Alterity Therapeutics Limited - Sponsored ADR (0.89%), Xilio Therapeutics, Inc. (16.52%), Clene Inc. (4.51%), Estrella Immunopharma, Inc. (2.08%), LAVA Therapeutics N.V. (0.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Bioxytran stock? Short selling BIXT is an investing strategy that aims to generate trading profit from Bioxytran as its price is falling. BIXT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bioxytran? A short squeeze for Bioxytran occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIXT, which in turn drives the price of the stock up even further. How often is Bioxytran's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIXT, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Acrivon Therapeutics Short Interest Data Karyopharm Therapeutics Short Interest Data Telomir Pharmaceuticals Short Interest Data Mersana Therapeutics Short Interest Data PepGen Short Interest Data Alterity Therapeutics Short Interest Data Xilio Therapeutics Short Interest Data Clene Short Interest Data Estrella Immunopharma Short Interest Data LAVA Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BIXT) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioxytran, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioxytran With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.